Literature DB >> 23978434

Hepatocellular carcinoma vascularization: from the most common to the lesser known arteries.

J Cazejust1, B Bessoud2, N Colignon2, C Garcia-Alba2, O Planché2, Y Menu2.   

Abstract

Hepatocellular carcinoma is the sixth most common cancer throughout the world. It is almost exclusively arterially vascularized, unlike the vascularization of the liver, which has a dual supply with a portal component of 75 to 80% and an arterial component of 20 to 25%. The reference treatment for intermediary stages of the Barcelona (B) classification is hepatic artery chemoembolization. The aim of chemoembolization is to inject the tumor chemotherapy into the artery and then to embolize the artery (or arteries), which supply the tumor. For this, knowledge of the anatomy of the hepatic artery is essential. Approximately 55% of the patients belong to the modal distribution, although numerous anatomical variants exist and must be recognized. In addition, primarily non-hepatic arteries may contribute to the vascularization of some hepatocellular carcinomas. Furthermore, new arterial supplies can be recruited by tumors after surgical or chemoembolization treatments. The aim of this article is to describe the different arteries, which may vascularize hepatocellular carcinomas. These arteries must be looked for, recognized, and reported by the radiologist on cross-section examinations in the pre-treatment assessment.
Copyright © 2013 Éditions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Angiography; Arterial anatomy of the liver; Chemoembolization; Hepatocellular carcinoma; Liver CT scan

Mesh:

Year:  2013        PMID: 23978434     DOI: 10.1016/j.diii.2013.04.015

Source DB:  PubMed          Journal:  Diagn Interv Imaging        ISSN: 2211-5684            Impact factor:   4.026


  11 in total

Review 1.  Therapeutic potential of small interfering RNAs/micro interfering RNA in hepatocellular carcinoma.

Authors:  Rossella Farra; Mario Grassi; Gabriele Grassi; Barbara Dapas
Journal:  World J Gastroenterol       Date:  2015-08-14       Impact factor: 5.742

2.  Fluorescence lifetime needle optical biopsy discriminates hepatocellular carcinoma.

Authors:  Evgenii A Zherebtsov; Elena V Potapova; Andrian V Mamoshin; Valery V Shupletsov; Ksenia Y Kandurova; Viktor V Dremin; Andrey Y Abramov; Andrey V Dunaev
Journal:  Biomed Opt Express       Date:  2022-01-06       Impact factor: 3.732

3.  Porcine and Human In Vivo Simulations for Doxorubicin-Containing Formulations Used in Locoregional Hepatocellular Carcinoma Treatment.

Authors:  Ilse R Dubbelboer; Erik Sjögren; Hans Lennernäs
Journal:  AAPS J       Date:  2018-08-30       Impact factor: 4.009

4.  Radioembolization versus portal vein embolization for contralateral liver lobe hypertrophy: effect of cirrhosis.

Authors:  Heiner Nebelung; Thomas Wolf; Sebastian Bund; Christoph Georg Radosa; Verena Plodeck; Sabine Grosche-Schlee; Carina Riediger; Ralf-Thorsten Hoffmann; Jens-Peter Kühn
Journal:  Abdom Radiol (NY)       Date:  2021-03-29

5.  Complete necrosis of hepatocellular carcinoma after preoperative portal vein embolization: a case report.

Authors:  H El Bacha; M Salihoun; N Kabbaj; A Benkabbou
Journal:  J Med Case Rep       Date:  2017-01-04

Review 6.  Polymer-Mediated Delivery of siRNAs to Hepatocellular Carcinoma: Variables Affecting Specificity and Effectiveness.

Authors:  Rossella Farra; Francesco Musiani; Francesca Perrone; Maja Čemažar; Urška Kamenšek; Federica Tonon; Michela Abrami; Aleš Ručigaj; Mario Grassi; Gabriele Pozzato; Deborah Bonazza; Fabrizio Zanconati; Giancarlo Forte; Maguie El Boustani; Lucia Scarabel; Marica Garziera; Concetta Russo Spena; Lucia De Stefano; Barbara Salis; Giuseppe Toffoli; Flavio Rizzolio; Gabriele Grassi; Barbara Dapas
Journal:  Molecules       Date:  2018-03-28       Impact factor: 4.411

Review 7.  Is the Rationale of Anatomical Liver Resection for Hepatocellular Carcinoma Universally Adoptable? A Hypothesis-Driven Review.

Authors:  Young-Jen Lin; Cheng-Maw Ho
Journal:  Medicina (Kaunas)       Date:  2021-02-02       Impact factor: 2.430

8.  Preoperative embolization strategy for the combined resection of replaced right hepatic artery in pancreaticoduodenectomy: a small case series.

Authors:  Shintaro Takeuchi; Yoshiyasu Ambo; Yoshihisa Kodama; Minoru Takada; Kentaro Kato; Fumitaka Nakamura; Satoshi Hirano
Journal:  Surg Case Rep       Date:  2022-03-22

9.  Efficacy of intra-arterial contrast-enhanced ultrasonography during transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma.

Authors:  Kazue Shiozawa; Manabu Watanabe; Takashi Ikehara; Shuhei Yamamoto; Takashi Matsui; Yoshinori Saigusa; Yoshinori Igarashi; Iruru Maetani
Journal:  World J Hepatol       Date:  2018-01-27

10.  Optical percutaneous needle biopsy of the liver: a pilot animal and clinical study.

Authors:  Viktor Dremin; Elena Potapova; Evgeny Zherebtsov; Ksenia Kandurova; Valery Shupletsov; Alexander Alekseyev; Andrian Mamoshin; Andrey Dunaev
Journal:  Sci Rep       Date:  2020-08-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.